发明授权
- 专利标题： Suicidal mutant Leishmania vaccine
- 专利标题（中）： 自杀突变利什曼原虫疫苗
-
申请号： US11091882申请日： 2005-03-28
-
公开(公告)号： US07238347B2公开(公告)日： 2007-07-03
- 发明人: Kwang-Poo Chang , Bala Krishna Kolli , Shigeru Sassa
- 申请人： Kwang-Poo Chang , Bala Krishna Kolli , Shigeru Sassa
- 申请人地址： US IL North Chicago
- 专利权人： Rosalind Franklin University of Medicine and Science
- 当前专利权人： Rosalind Franklin University of Medicine and Science
- 当前专利权人地址： US IL North Chicago
- 代理机构： Everest Intellectual Property Law Group
- 代理商 Tin-Chuen Yeung
- 主分类号： A61K48/00
- IPC分类号： A61K48/00 ; A61K39/08
摘要：
The present invention discloses the use of a mutant Leishmania as a suicidal vaccine wherein the mutant Leishmania is responsive to external signals to become porphyric and commit suicidal cytolysis. The mutant can be selected from natural Leishmania species or constructed by genetic engineering.
公开/授权文献
- US20060018888A1 Suicidal mutant leishmania vaccine 公开/授权日：2006-01-26
信息查询
